Background: Carbapenem-resistant has become a significant public health concern as hospital outbreaks are now being frequently reported and these organisms are becoming difficult to treat with the available antibiotics.
Case Summary: An outbreak of VIM-producing occurred over a period of 11 wk (August, 1 to October, 18) in patients admitted to the adult polyvalent intensive care unit of the University of Campania "Luigi Vanvitelli" located in Naples. Four episodes occurred in three patients (two patients infected, and one patient colonized). All the strains revealed the production of VIM.
Conclusion: After three decades of carbapenem antibiotics use, the emergence of carbapenem-resistance in has become a significant concern and a stricter control to preserve its clinical application is mandatory. This is, to our knowledge, the first outbreak of VIM-producing in Europe. Surveillance policies must be implemented to avoid future outbreaks.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854422 | PMC |
| http://dx.doi.org/10.12998/wjcc.v7.i21.3535 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multiple regional outbreaks caused by global and local VIM-producing Klebsiella pneumoniae clones in Poland, 2006-2019.
Eur J Clin Microbiol Infect Dis
December 2024
Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland.
Purpose: This study was aimed at comprehensive genomic analysis of VIM-type carbapenemase-producing Klebsiella pneumoniae species complex (KpSC) in Poland.
Methods: All non-duplicate 214 VIM-producing KpSC isolates reported in Poland in 2006-2019 were short-read sequenced and re-identified by the average nucleotide identity scoring. Their clonality/phylogeny was assessed by cgMLST and SNP in comparison with genomes from international databases.
Long-term ICU outbreak of carbapenamase-producing organisms associated with contaminated sink drains.
J Hosp Infect
October 2023
Department of Clinical Microbiology, Cliniques universitaires Saint-Luc, Brussels, Belgium; Medical Microbiology Unit, Institute of Experimental and Clinical Research, Université catholique de Louvain (UCLouvain), Brussels, Belgium; Department of Prevention and Control Infection, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Article Synopsis
- A Belgian hospital's ICU experienced a long-term outbreak of carbapenemase-producing organisms (CPO), specifically PA-VIM and CPE-NDM, from 2018 to 2022, affecting many hospitalized patients.
- The study utilized various methods such as active case finding, environmental sampling, and whole genome sequencing to investigate the outbreak and found a connection between clinical infections and environmental strains in sink drains.
- Despite efforts to disinfect and manage contaminated equipment, resistance to disinfection methods persisted, highlighting the urgent need for innovative strategies to tackle persistent bacterial reservoirs and prevent CPO transmission in healthcare settings.
Five-year VIM-producing Pseudomonas aeruginosa outbreak in four Belgian ICUs, an investigation report (2019-2023).
Am J Infect Control
December 2024
Vrije Universiteit Brussel (VUB), Department of Statistic: Support for Quantitative and Qualitative Research (SQUARE), Brussels, Belgium.
Background: Verona integron-encoded metallo-β-lactamase-producing Pseudomonas aeruginosa (VIM-PA) outbreaks are frequently linked to contaminated sink-drains in the intensive care unit (ICU). This study aims to investigate a VIM-PA outbreak occurring at 4 ICUs in a Belgian university center.
Methods: Between 01/01/2019 and 30/07/2023, data were retrospectively retrieved.
A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance.
Antimicrob Agents Chemother
April 2024
Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Carbapenem resistance due to metallo-β-lactamases (MBLs) such as the Verona integron-encoded metallo-β-lactamase (VIM) is particularly problematic due to the limited treatment options. We describe a case series of bacterial infections in a tertiary care hospital due to multi-species acquisition of a VIM gene along with our experience using novel β-lactam antibiotics and antibiotic combinations to treat these infections. Four patients were treated with the combination of ceftazidime-avibactam and aztreonam, with no resistance to the combination detected.
View Article and Find Full Text PDFLong-term intensive care unit outbreak of carbapenemase-producing organisms associated with contaminated sink drains.
J Hosp Infect
January 2024
Department of Clinical Microbiology, Cliniques universitaires Saint-Luc, Brussels, Belgium; Medical Microbiology Unit, Institute of Experimental and Clinical Research, Université catholique de Louvain (UCLouvain), Brussels, Belgium; Department of Prevention and Control Infection, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Background: Between 2018 and 2022, a Belgian tertiary care hospital faced a growing issue with acquiring carbapenemase-producing organisms (CPO), mainly VIM-producing P. aeruginosa (PA-VIM) and NDM-producing Enterobacterales (CPE-NDM) among hospitalized patients in the adult intensive care unit (ICU).
Aim: To investigate this ICU long-term CPO outbreak involving multiple species and a persistent environmental reservoir.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!